</>Build with Tariff Intelligence|Programmatic access to tariff calculations and HS code classification.Explore Developer Resources →

Meropenem 500mg Intravenous Injection Vial from Japan

This is a sterile, single-dose vial containing 500mg of meropenem powder for reconstitution into a solution for intravenous administration to treat severe bacterial infections. It falls under HTS 3004.20.00.76 as a medicament containing meropenem, put up in measured doses for therapeutic use against antibiotic-resistant bacteria. The product is unmixed meropenem or its salts, specifically formulated for hospital IV delivery.

Duty Rate — Japan → United States

15%

Rate breakdown

9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)

Import Tips

Obtain FDA approval and provide Certificate of Pharmaceutical Product (CPP) from the manufacturing country for import clearance

Verify batch-specific stability data and ensure cold chain logistics to maintain potency during transit

Avoid misclassification by confirming the product contains only meropenem or its salts without other active ingredients

Meropenem 500mg Intravenous Injection Vial from Japan — Import Duty Rate | HTS 3004.20.00.76